Correlation Between Bristol-Myers Squibb and ONCOR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and ONCOR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and ONCOR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and ONCOR ELEC DELIVERY, you can compare the effects of market volatilities on Bristol-Myers Squibb and ONCOR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of ONCOR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and ONCOR.

Diversification Opportunities for Bristol-Myers Squibb and ONCOR

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bristol-Myers and ONCOR is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and ONCOR ELEC DELIVERY in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ONCOR ELEC DELIVERY and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with ONCOR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ONCOR ELEC DELIVERY has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and ONCOR go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and ONCOR

Assuming the 90 days horizon Bristol Myers Squibb is expected to generate 12.08 times more return on investment than ONCOR. However, Bristol-Myers Squibb is 12.08 times more volatile than ONCOR ELEC DELIVERY. It trades about 0.08 of its potential returns per unit of risk. ONCOR ELEC DELIVERY is currently generating about 0.0 per unit of risk. If you would invest  74,000  in Bristol Myers Squibb on September 1, 2024 and sell it today you would earn a total of  26,555  from holding Bristol Myers Squibb or generate 35.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy97.6%
ValuesDaily Returns

Bristol Myers Squibb  vs.  ONCOR ELEC DELIVERY

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol-Myers Squibb reported solid returns over the last few months and may actually be approaching a breakup point.
ONCOR ELEC DELIVERY 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ONCOR ELEC DELIVERY has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ONCOR is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Bristol-Myers Squibb and ONCOR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol-Myers Squibb and ONCOR

The main advantage of trading using opposite Bristol-Myers Squibb and ONCOR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, ONCOR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ONCOR will offset losses from the drop in ONCOR's long position.
The idea behind Bristol Myers Squibb and ONCOR ELEC DELIVERY pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios